Skip to main content
Premium Trial:

Request an Annual Quote

Indivumed, Intermed Form Strategic Alliance

NEW YORK (GenomeWeb) – Indivumed and medical logistics firm Intermed have signed a new strategic alliance, the two companies said today.

Under the terms of the agreement, Intermed is investing in Indivumed to support expansion of the firm's leading cancer database in Germany. In addition, Intermed will help distribute Indivumed's diagnostic tests through its partnership with the physician-managed laboratory network LADR Laborverbund.

Indivumed's cancer database includes unique patterns of RNA, DNA, and proteins as they exist in the human body, allowing for multi-omics studies of samples with relevant biologic and clinical information. Through its IndivuTest subsidiary, Indivumed also offers diagnostic services, including genomic analyses of tissue and blood to personalize therapy for cancer patients.

"We are very glad to receive logistical support for the expansion of our cancer database and, at the same time, be able to provide Central European-wide highly innovative diagnostic tests for personalized cancer medicine," Indivumed Founder and CEO Hartmut Juhl said in a statement.


The Scan

Denisovan Girl's Tooth Found in Laos

CNN reports that a tooth found in a cave north of Vientiane likely belonged to a Denisovan girl.

A Lack of Diversity in Trials

A new report from the National Academies of Science, Engineering, and Medicine examines the limited representation of diverse groups among clinical trial participants.

Another Look

A new inquiry is to be held after genetic evidence indicates that Kathleen Folbigg's children may have been at increased risk of sudden death, the Sydney Morning Herald reports.

Nucleic Acids Research Studies on ICARUS, Neighbor-seq, CADDIE

In Nucleic Acids Research this week: resource to analyze and visualize single-cell RNA-seq data, method to examine cellular interactions, and more.